-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, DnSpbP7HJv1AlXyyc/yLC43+19FoSwUQq57oUfG9ubv/OQtBp7rGuwVEExN5iUaZ bUtaUTiGlGxRoz+lpvpJnA== 0000872947-11-000004.txt : 20110124 0000872947-11-000004.hdr.sgml : 20110124 20110124124751 ACCESSION NUMBER: 0000872947-11-000004 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110119 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Other Events FILED AS OF DATE: 20110124 DATE AS OF CHANGE: 20110124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: APPLIED NEUROSOLUTIONS INC CENTRAL INDEX KEY: 0000872947 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 391661164 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13835 FILM NUMBER: 11543192 BUSINESS ADDRESS: STREET 1: 50 LAKEVIEW PARKWAY S STREET 2: STE 111 CITY: VERNON HILLS STATE: IL ZIP: 60061 BUSINESS PHONE: 847 573 8000 MAIL ADDRESS: STREET 1: 50 LAKEVIEW PARKWAY STREET 2: STE 111 CITY: VERNON HILLS STATE: IL ZIP: 60061 FORMER COMPANY: FORMER CONFORMED NAME: HEMOXYMED INC DATE OF NAME CHANGE: 20020820 FORMER COMPANY: FORMER CONFORMED NAME: OPHIDIAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 19970714 8-K 1 apnscurrentreport.htm APPLIED NEUROSOLUTIONS 8-K 01-19-2011 apnscurrentreport.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549
 
FORM 8-K

 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 
Date of Report (Date of earliest event reported)    January 19, 2011
 
APPLIED NEUROSOLUTIONS, INC.
(Exact name of Registrant as Specified in its Charter)
 
Delaware   001-13835     39-1661164
  (State or Other Jurisdiction of Incorporation)     (Commission file Number)     (IRS Employer Identification No.)
 

 
 50 Lakeview Parkway, Suite 111, Vernon Hills, IL    60061
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code (847) 573-8000
 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

 
 
 
 
Section 8 – Other Events
 
Item 8.01 – Other Events
 
Applied NeuroSolutions, Inc. (the “Registrant”) has previously disclosed its need to raise funds to continue its operations as a virtual company.  The Registrant had discontinued funding its Alzheimer’s disease (“AD”) diagnostic programs, terminated all employees and shut down its office and lab space.  Due to the lack of funding, the Registrant lost the exclusive licensing rights to its AD technology with Albert Einstein College of Medicine of Yeshiva University.
 
The Registrant has not been able to secure funding, thus, the Registrant’s Board of Directors has elected to cease the Registrant’s operations, effective immediately.
 
Section 5 – Corporate Governance and Management
 
Item 5.02. – Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
On January 19, 2011, in conjunction with the items outlined above, the Board of Directors of the Registrant, Ellen R. Hoffing, Edward A. Ogunro, Ph.D., Gary C. Parks and David C. Tiemeier, Ph.D., resigned.  In addition, David Ellison, the acting CEO and CFO also resigned.


 
1 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 19th day of January 2011.
 
  APPLIED NEUROSOLUTIONS, INC.  
       
 
By:
/s/  David Ellison  
    Name:  David Ellison  
    Title:  Acting CEO and CFO  
       
 
 
 
 
 
2 
 -----END PRIVACY-ENHANCED MESSAGE-----